Neutrophil Extracellular Trap Formation Potential Correlates with Lung Disease Severity in COVID-19 Patients.
Neutrophil Extracellular Trap Formation Potential Correlates with Lung Disease Severity in COVID-19 Patients.
复制标题
DOI:
10.1007/s10753-021-01585-x
复制
发表时间:
2022-04
期刊:
影响因子:
5.1
通讯作者:
Moreland JG
中科院分区:
文献类型:
--
作者:
Kinnare N;Hook JS;Patel PA;Monson NL;Moreland JG
Severe lung inflammation is common in life-threatening coronavirus disease 2019 (COVID-19). This study tested the hypothesis that polymorphonuclear (PMN, neutrophil) phenotype early in the course of disease progression would predict peak lung disease severity in patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is increasingly evident that PMN activation contributes to tissue injury resulting from extracellular reactive oxygen species generation, granule exocytosis with release of proteases, neutrophil extracellular trap (NET) formation, and release of cytokines. The current study focuses on PMN activation in response to SARS-CoV-2 infection, specifically, the association between NETs and lung disease. This is a prospective cohort study at an academic medical center with patients enrolled within 4 days of admission at 3 tertiary hospitals: Clements University Hospital, Parkland Memorial Hospital, and Children’s Health in Dallas, TX. Patients were categorized as having minimal or moderate to severe lung disease based on peak respiratory support. Healthy donor controls matched for age, sex, race, and ethnicity were also enrolled. Neutrophils from COVID-19 patients displayed greater IL-8 expression, elastase release, and NET formation as compared with neutrophils from healthy donors. Importantly, neutrophils from COVID-19 patients had enhanced NET formation in the absence of any additional stimulus, not seen in PMN from healthy donors. Moreover, PMA-elicited NET formation by circulating PMN correlated with severity of lung disease. We speculate that neutrophil immuno-phenotyping can be used to predict lung disease severity in COVID-19 patients. The online version contains supplementary material available at 10.1007/s10753-021-01585-x.
登录
查看更多内容
影响因子:
7.3
作者:
Hazeldine J;Lord JM
通讯作者:
Lord JM
影响因子:
7.3
作者:
Cortjens, Bart;de Boer, Onno J.;Bem, Reinout A.
通讯作者:
Bem, Reinout A.
影响因子:
2.4
作者:
Kohira, Satoshi;Oka, Norihiko;Miyaji, Kagami
通讯作者:
Miyaji, Kagami
影响因子:
82.9
作者:
Del Valle DM;Kim-Schulze S;Huang HH;Beckmann ND;Nirenberg S;Wang B;Lavin Y;Swartz TH;Madduri D;Stock A;Marron TU;Xie H;Patel M;Tuballes K;Van Oekelen O;Rahman A;Kovatch P;Aberg JA;Schadt E;Jagannath S;Mazumdar M;Charney AW;Firpo-Betancourt A;Mendu DR;Jhang J;Reich D;Sigel K;Cordon-Cardo C;Feldmann M;Parekh S;Merad M;Gnjatic S
通讯作者:
Gnjatic S
DOI:
10.1016/j.mcpro.2021.100113
发表时间:
2021
期刊:
Molecular & cellular proteomics : MCP
影响因子:
--
作者:
Fisher J;Mohanty T;Karlsson CAQ;Khademi SMH;Malmström E;Frigyesi A;Nordenfelt P;Malmstrom J;Linder A
通讯作者:
Linder A